TY - JOUR
T1 - Interrelation between myocardial oxidative metabolism and diastolic function in patients undergoing surgical ventricular reconstruction
AU - Chiba, Satoru
AU - Naya, Masanao
AU - Iwano, Hiroyuki
AU - Yoshinaga, Keiichiro
AU - Katoh, Chietsugu
AU - Manabe, Osamu
AU - Yamada, Satoshi
AU - Wakasa, Satoru
AU - Kubota, Suguru
AU - Matsui, Yoshiro
AU - Tamaki, Nagara
AU - Tsutsui, Hiroyuki
N1 - Funding Information:
Funding This work was supported by a Grant in Aid provided by Japan Society for the Promotion of Science (SC) [No. 22591313].
PY - 2013/2
Y1 - 2013/2
N2 - Purpose: Diastolic function is impaired in patients with end-stage heart failure. Favorable structural changes by surgical ventricular reconstruction (SVR) are thought to improve diastolic function, however, previous studies reported the contradictory results. We hypothesized that cardiac oxidative metabolism and diastolic dysfunction might improve in parallel to the reduction of left ventricular chamber size after SVR. Methods: We studied 11 patients underwent SVR associated with mitral valve repair for end-stage heart failure due to dilated cardiomyopathy. Diastolic function was assessed by echocardiography and myocardial oxidative metabolism was measured by the monoexponential clearance (k-mono) of 11C-acetate positron emission tomography at baseline and 1 month after SVR. Results: All patients had preoperative severe diastolic dysfunction [E/A 4.11 ± 1.18, deceleration time (DT) 134 ± 26 ms]. The study patients were divided into 2 groups according to the changes in diastolic function after SVR; unchanged or worsened diastolic function in 6 patients (55 %, Non-responder) and improved diastolic function in 5 (45 %, Responder). K-mono and wall stress decreased only in responder. The changes in k-mono before and after SVR correlated with those in deceleration time (r = -0.63; p < 0.05) and wall stress (r = 0.75; p < 0.01). Conclusions: Improvement of diastolic dysfunction in patients with end-stage heart failure by SVR was in parallel to that in oxidative metabolism. It suggests that SVR reduced excessive metabolism during the diastolic phase, in part, via the improvement in diastolic function and the reduction in LV wall stress.
AB - Purpose: Diastolic function is impaired in patients with end-stage heart failure. Favorable structural changes by surgical ventricular reconstruction (SVR) are thought to improve diastolic function, however, previous studies reported the contradictory results. We hypothesized that cardiac oxidative metabolism and diastolic dysfunction might improve in parallel to the reduction of left ventricular chamber size after SVR. Methods: We studied 11 patients underwent SVR associated with mitral valve repair for end-stage heart failure due to dilated cardiomyopathy. Diastolic function was assessed by echocardiography and myocardial oxidative metabolism was measured by the monoexponential clearance (k-mono) of 11C-acetate positron emission tomography at baseline and 1 month after SVR. Results: All patients had preoperative severe diastolic dysfunction [E/A 4.11 ± 1.18, deceleration time (DT) 134 ± 26 ms]. The study patients were divided into 2 groups according to the changes in diastolic function after SVR; unchanged or worsened diastolic function in 6 patients (55 %, Non-responder) and improved diastolic function in 5 (45 %, Responder). K-mono and wall stress decreased only in responder. The changes in k-mono before and after SVR correlated with those in deceleration time (r = -0.63; p < 0.05) and wall stress (r = 0.75; p < 0.01). Conclusions: Improvement of diastolic dysfunction in patients with end-stage heart failure by SVR was in parallel to that in oxidative metabolism. It suggests that SVR reduced excessive metabolism during the diastolic phase, in part, via the improvement in diastolic function and the reduction in LV wall stress.
UR - http://www.scopus.com/inward/record.url?scp=84873988093&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873988093&partnerID=8YFLogxK
U2 - 10.1007/s00259-012-2297-3
DO - 10.1007/s00259-012-2297-3
M3 - Article
C2 - 23184309
AN - SCOPUS:84873988093
SN - 1619-7070
VL - 40
SP - 349
EP - 355
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
IS - 3
ER -